Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact on +44 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Testimonials
Thank you ever so much for all the hard work you put in. Zenopa's service was second to none, especially as you offered your service outside of office hours which was appreciated.
Nikki, 2013

Future Science Group launches Pharmaceutical Patent Analyst journal

5 March 2012 00:00 in Marketing Services


Future Science Group has announced the launch of a new journal named Pharmaceutical Patent Analyst, which will discuss important patent issues pertaining to pharmaceutical and medical science.

The bi-monthly peer-reviewed publication will focus on high-impact patent reviews pertaining to significant areas of research, including new therapies, drug-delivery systems and medical devices, as well as bio- and nanotechnology innovations.

It will be supported by a multidisciplinary editorial board that includes academy and industry-based researchers and opinion leaders, as well as specialists in intellectual property (IP).

Heading the editorial board will be Professor David Rotella of Montclair State University and Dr Lyn Jones of Pfizer.

Elisa Manzotti, publisher at Future Science Group, said: "We are extremely grateful to the senior editors and editorial board for bringing their specialist expertise to bear to create a substantial publication that genuinely addresses core IP issues in biomedicine and biotechnology."

This comes after the company introduced Colorectal Cancer, an oncology-focused medical journal, in February 2012.ADNFCR-8000103-ID-801309847-ADNFCR

Other news stories from 05/03/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd